Details for New Drug Application (NDA): 050509
✉ Email this page to a colleague
NDA 050509 describes CYCLAPEN-W, which is a drug marketed by Wyeth Ayerst and is included in two NDAs. Additional details are available on the CYCLAPEN-W profile page.
The generic ingredient in CYCLAPEN-W is cyclacillin. There are two drug master file entries for this compound. Additional details are available on the cyclacillin profile page.
The generic ingredient in CYCLAPEN-W is cyclacillin. There are two drug master file entries for this compound. Additional details are available on the cyclacillin profile page.
Summary for 050509
| Tradename: | CYCLAPEN-W |
| Applicant: | Wyeth Ayerst |
| Ingredient: | cyclacillin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050509
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
